Hypoxic respiratory failure in term newborns: clinical indicators for inhaled nitric oxide and extracorporeal membrane oxygenation therapy

被引:14
作者
Fakioglu, H [1 ]
Totapally, BR [1 ]
Torbati, D [1 ]
Raszynski, A [1 ]
Sussmane, JB [1 ]
Wolfsdorf, J [1 ]
机构
[1] Miami Childrens Hosp, Div Crit Care Med, Miami, FL 33155 USA
关键词
extracorporeal membrane oxygenation; hypoxic respiratory failure; inhaled nitric oxide; persistent pulmonary hypertension of newborn; term newborns;
D O I
10.1016/j.jcrc.2005.05.011
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Purpose: The criteria, for starting extracorporeal membrane oxygenation (ECMO) therapy in term newborn patients with hypoxemic respiratory failure consist of. an oxygenation index (OI) of 25 or higher and alveolar-arterial oxygen (AaO(2)) gradient of more than 600 at sea level. In such. conditions, inhaled. nitric oxide. (iNO) may improve oxygenation and reduce the need for ECMO therapy. We studied early changes in OI and AaO(2) gradients in response to iNO treatment that may indicate a need to continue iNO treatment or the necessity to start an. ECMO therapy. Materials and Methods: In this prospective study, we used 34 outborn neonatal patients that were referred to our pediatric critical care unit in a. children's hospital for ECMO therapy with diagnosis of hypoxemic respiratory failure. In all patients, iNO therapy, starting. at 80 ppm,, was. instituted either during transport or on arrival to hospital. Response, to iNO was assessed after 1 hour, at which time, iNO concentration was reduced to 40 ppm, provided there was more than 20% improvement in either or both oxygenation indices. Patients who,did not respond positively to continuous iNO therapy and met ECMO criteria were given ECMO therapy. Results: Inhaled nitric oxide therapy alone was successful in 10 (29%) of 34 patients. Eighteen patients (53%) required ECMO therapy within the first 10 hours of iNO treatment (early ECMO therapy), whereas. 6 other neonates (18%) became eligible for ECMO therapy after prolonged (2-4 days) iNO treatment (late ECMO therapy). No mortality occurred with. any treatment. Within 4 hours after iNO therapy patients who required early ECMO therapy had significantly higher OI and AaO(2) gradients than patients who were treated with iNO therapy alone. (P <.01, analysis of variance followed by Tukey-Kramer multiple comparison test). Six of 34,patients (18%), categorized as late ECMO therapy, on the average, had initially higher levels of OI and mean airway, pressure than neonates in iNO treatment and early ECMO therapy. Conclusion: Persisting levels of OI of more than 20 or AaO(2) gradients of more than 600 after 4 hours of iNO therapy could be indicative of an immediate need for ECMO therapy. (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:288 / 293
页数:6
相关论文
共 50 条
  • [21] Technological advances in extracorporeal membrane oxygenation for respiratory failure
    Rehder, Kyle J.
    Turner, David A.
    Bonadonna, Desiree
    Walczak, Richard J.
    Rudder, Robert J.
    Cheifetz, Ira M.
    EXPERT REVIEW OF RESPIRATORY MEDICINE, 2012, 6 (04) : 377 - 384
  • [22] Extracorporeal membrane oxygenation for severe acute respiratory failure
    Lewandowski, K
    CRITICAL CARE, 2000, 4 (03): : 156 - 168
  • [23] Inhaled nitric oxide for avoidance of extracorporeal membrane oxygenation in the treatment of severe persistent pulmonary hypertension of the newborn
    Muller, W
    Kachel, W
    Lasch, P
    Varnholt, V
    Konig, SA
    INTENSIVE CARE MEDICINE, 1996, 22 (01) : 71 - 76
  • [24] Inhaled nitric oxide during extracorporeal membrane oxygenation for the treatment of severe persistent pulmonary hypertension of the newborn
    Muller, W
    Kachel, W
    Lasch, P
    Varnholt, V
    Konig, S
    ARTIFICIAL ORGANS, 1996, 20 (01) : 60 - 63
  • [25] The Evolution of the Use of Extracorporeal Membrane Oxygenation in Respiratory Failure
    Feldhaus, Danielle
    Brodie, Daniel
    Lemaitre, Philippe
    Sonett, Joshua
    Agerstrand, Cara
    MEMBRANES, 2021, 11 (07)
  • [26] Extracorporeal Membrane Oxygenation for Respiratory Failure: A Narrative Review
    Grotberg, John C.
    Reynolds, Daniel
    Kraft, Bryan D.
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (13)
  • [27] The Evolution of Extracorporeal Membrane Oxygenation for Adult Respiratory Failure
    Brodie, Daniel
    ANNALS OF THE AMERICAN THORACIC SOCIETY, 2018, 15 : S57 - S60
  • [28] Venovenous extracorporeal membrane oxygenation for acute respiratory failure
    Fan, Eddy
    Gattinoni, Luciano
    Combes, Alain
    Schmidt, Matthieu
    Peek, Giles
    Brodie, Dan
    Muller, Thomas
    Morelli, Andrea
    Ranieri, V. Marco
    Pesenti, Antonio
    Brochard, Laurent
    Hodgson, Carol
    Van Kiersbilck, Cecile
    Roch, Antoine
    Quintel, Michael
    Papazian, Laurent
    INTENSIVE CARE MEDICINE, 2016, 42 (05) : 712 - 724
  • [29] Efficacy of Inhaled Nitric Oxide for Hypoxic Respiratory Failure in Term and Late Preterm Infants by Baseline Severity of Illness: A Pooled Analysis of Three Clinical Trials
    Golombek, Sergio G.
    Young, Joseph N.
    CLINICAL THERAPEUTICS, 2010, 32 (05) : 939 - 948
  • [30] Extracorporeal membrane oxygenation for paediatric refractory hypoxic respiratory failure caused by adenovirus in Shanghai: a case series
    Yun Cui
    Jingyi Shi
    Yiping Zhou
    Jiaying Dou
    Xi Xiong
    Ting Sun
    Yijun Shan
    Tingting Xu
    Ye Lu
    Yucai Zhang
    BMC Pediatrics, 22